These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 27544755)
61. Nrf2 is the key to chemotherapy resistance in MCF7 breast cancer cells under hypoxia. Syu JP; Chi JT; Kung HN Oncotarget; 2016 Mar; 7(12):14659-72. PubMed ID: 26894974 [TBL] [Abstract][Full Text] [Related]
62. Catalase suppression-mediated H(2)O(2) accumulation in cancer cells by wogonin effectively blocks tumor necrosis factor-induced NF-κB activation and sensitizes apoptosis. Yang L; Zheng XL; Sun H; Zhong YJ; Wang Q; He HN; Shi XW; Zhou B; Li JK; Lin Y; Zhang L; Wang X Cancer Sci; 2011 Apr; 102(4):870-6. PubMed ID: 21244577 [TBL] [Abstract][Full Text] [Related]
63. Evaluation of the cytotoxicity of the Bithionol - cisplatin combination in a panel of human ovarian cancer cell lines. Ayyagari VN; Hsieh TJ; Diaz-Sylvester PL; Brard L BMC Cancer; 2017 Jan; 17(1):49. PubMed ID: 28086831 [TBL] [Abstract][Full Text] [Related]
64. Role of the Nrf2-antioxidant system in cytotoxicity mediated by anticancer cisplatin: implication to cancer cell resistance. Cho JM; Manandhar S; Lee HR; Park HM; Kwak MK Cancer Lett; 2008 Feb; 260(1-2):96-108. PubMed ID: 18036733 [TBL] [Abstract][Full Text] [Related]
65. Inhibition of heme oxygenase-1 enhances the chemosensitivity of laryngeal squamous cell cancer Hep-2 cells to cisplatin. Lv X; Song DM; Niu YH; Wang BS Apoptosis; 2016 Apr; 21(4):489-501. PubMed ID: 26801320 [TBL] [Abstract][Full Text] [Related]
66. Anti-tumor and anti-metastatic actions of wogonin isolated from Scutellaria baicalensis roots through anti-lymphangiogenesis. Kimura Y; Sumiyoshi M Phytomedicine; 2013 Feb; 20(3-4):328-36. PubMed ID: 23219337 [TBL] [Abstract][Full Text] [Related]
67. Wogonin induces apoptosis and down-regulates survivin in human breast cancer MCF-7 cells by modulating PI3K-AKT pathway. Huang KF; Zhang GD; Huang YQ; Diao Y Int Immunopharmacol; 2012 Feb; 12(2):334-41. PubMed ID: 22182776 [TBL] [Abstract][Full Text] [Related]
68. HDAC4 degradation by combined TRAIL and valproic acid treatment induces apoptotic cell death of TRAIL-resistant head and neck cancer cells. Lee BS; Kim YS; Kim HJ; Kim DH; Won HR; Kim YS; Kim CH Sci Rep; 2018 Aug; 8(1):12520. PubMed ID: 30131570 [TBL] [Abstract][Full Text] [Related]
69. Potential use of cetrimonium bromide as an apoptosis-promoting anticancer agent for head and neck cancer. Ito E; Yip KW; Katz D; Fonseca SB; Hedley DW; Chow S; Xu GW; Wood TE; Bastianutto C; Schimmer AD; Kelley SO; Liu FF Mol Pharmacol; 2009 Nov; 76(5):969-83. PubMed ID: 19654225 [TBL] [Abstract][Full Text] [Related]
70. Cyclin-dependent kinase inhibitor dinaciclib potently synergizes with cisplatin in preclinical models of ovarian cancer. Chen XX; Xie FF; Zhu XJ; Lin F; Pan SS; Gong LH; Qiu JG; Zhang WJ; Jiang QW; Mei XL; Xue YQ; Qin WM; Shi Z; Yan XJ Oncotarget; 2015 Jun; 6(17):14926-39. PubMed ID: 25962959 [TBL] [Abstract][Full Text] [Related]
71. Activation of the NRF2-ARE signalling pathway by the Lentinula edodes polysaccharose LNT alleviates ROS-mediated cisplatin nephrotoxicity. Chen Q; Peng H; Dong L; Chen L; Ma X; Peng Y; Dai S; Liu Q Int Immunopharmacol; 2016 Jul; 36():1-8. PubMed ID: 27093515 [TBL] [Abstract][Full Text] [Related]
72. Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer. Casagrande N; De Paoli M; Celegato M; Borghese C; Mongiat M; Colombatti A; Aldinucci D Gynecol Oncol; 2013 Dec; 131(3):744-52. PubMed ID: 24029417 [TBL] [Abstract][Full Text] [Related]
73. Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism. Ren D; Villeneuve NF; Jiang T; Wu T; Lau A; Toppin HA; Zhang DD Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1433-8. PubMed ID: 21205897 [TBL] [Abstract][Full Text] [Related]
74. Targeting CDK9 by wogonin and related natural flavones potentiates the anti-cancer efficacy of the Bcl-2 family inhibitor ABT-263. Polier G; Giaisi M; Köhler R; Müller WW; Lutz C; Buss EC; Krammer PH; Li-Weber M Int J Cancer; 2015 Feb; 136(3):688-98. PubMed ID: 24895203 [TBL] [Abstract][Full Text] [Related]
75. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway. Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220 [TBL] [Abstract][Full Text] [Related]
76. Wogonin induces apoptosis and endoplasmic reticulum stress in HL-60 leukemia cells through inhibition of the PI3K-AKT signaling pathway. Hu C; Xu M; Qin R; Chen W; Xu X Oncol Rep; 2015 Jun; 33(6):3146-54. PubMed ID: 25846394 [TBL] [Abstract][Full Text] [Related]
77. Wogonin, an active ingredient of Chinese herb medicine Scutellaria baicalensis, inhibits the mobility and invasion of human gallbladder carcinoma GBC-SD cells by inducing the expression of maspin. Dong P; Zhang Y; Gu J; Wu W; Li M; Yang J; Zhang L; Lu J; Mu J; Chen L; Li S; Wang J; Liu Y J Ethnopharmacol; 2011 Oct; 137(3):1373-80. PubMed ID: 21855619 [TBL] [Abstract][Full Text] [Related]
78. Emodin enhances cisplatin-induced cytotoxicity in human bladder cancer cells through ROS elevation and MRP1 downregulation. Li X; Wang H; Wang J; Chen Y; Yin X; Shi G; Li H; Hu Z; Liang X BMC Cancer; 2016 Aug; 16():578. PubMed ID: 27485374 [TBL] [Abstract][Full Text] [Related]
79. Violacein, an indole-derived purple-colored natural pigment produced by Janthinobacterium lividum, inhibits the growth of head and neck carcinoma cell lines both in vitro and in vivo. Masuelli L; Pantanella F; La Regina G; Benvenuto M; Fantini M; Mattera R; Di Stefano E; Mattei M; Silvestri R; Schippa S; Manzari V; Modesti A; Bei R Tumour Biol; 2016 Mar; 37(3):3705-17. PubMed ID: 26462840 [TBL] [Abstract][Full Text] [Related]